Sidley Austin is advising Mastercard on the transaction, and Willkie Farr & Gallagher is advising Recorded Future. Wilson Sonsini Goodrich & Rosati is advising Mastercard on...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised SpectraWAVE on the transaction. SpectraWAVE, Inc., a medical imaging company, has announced raising $50 million in Series B funding round...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Cellino Biotech, Inc. on the transaction. Cellino Biotech, Inc. (Cellino) announced that the Advanced Research Projects Agency for Health (ARPA-H),...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Syxsense on the transaction. Absolute Security, announced it acquired Syxsense, a provider of automated endpoint and vulnerability management. Financial terms...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised JP Morgan Life Sciences Private Capital on the transaction. Pathalys Pharma, Inc., a private biopharmaceutical company in the late stages...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised eGenesis on the transaction. eGenesis, a biotechnology company developing human-compatible engineered organs to address the global organ shortage, announced the...
You must be a Standard 1 Year member to access this content.
Latham & Watkins advised Avidity Biosciences on the deal, and Wilson Sonsini Goodrich & Rosati acted as patent counsel to Avidity. Avidity Biosciences, Inc. (Nasdaq: RNA),...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati assisted Scale Computing, Inc. on the matter, and McDermott Will & Emery assisted DataCore Software Corporation. Scale Computing, a market leader...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Borealis Biosciences on the transaction. Borealis Biosciences (Borealis), a next-generation RNA medicines company, emerged from stealth with $150 million in...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised Neptune Medical on the transaction. Neptune Medical, a leader in medical device innovation, announced the closing of a $97 million...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati represented Trove in the transaction. Trove, a leader in branded resale and customer trade-in, announced the acquisition of Recurate, a leading...
You must be a Standard 1 Year member to access this content.
Wilson Sonsini Goodrich & Rosati advised MBX Biosciences on patent matters on the transaction. MBX Biosciences, Inc., a clinical-stage biopharmaceutical company, announced a $63.5 million Series...
You must be a Standard 1 Year member to access this content.
